VAERS reports by lot

Merck Pneumococcal lot N022650: VAERS reports

49 VAERS reports list lot N022650 as a Merck Pneumococcal vaccine, received between 2017-10-06 and 2018-10-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
49
Reports
10%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7949%
General / Systemic (non-local)1912%
Allergic / Anaphylactic1711%
Musculoskeletal128%
Dermatological (non-injection-site)106%
Neurological85%
Cardiac / Cardiovascular64%
Respiratory42%
Gastrointestinal32%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Illinois4
Missouri4
South Carolina2
Iowa2
Michigan2
Wisconsin2
Maryland2
Colorado2
North Carolina2
Hawaii2
Oregon2

Reports by month received

2017-1011
2017-1112
2017-1210
2018-015
2018-022
2018-031
2018-051
2018-062
2018-071
2018-083
2018-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.